NeuroBo Pharmaceuticals Stock Quote NRBO - Stock Price, News, Charts, Message Board, Trades

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

Current Price

2.36

Bid

2.31

Ask

2.49

Volume

0.00 Day's Range 0.00

2.08 52 Week Range 6.7499

Market Cap

20.334M

Previous Close

2.36

Open

Last Trade

Last Trade Time

Financial Volume

VWAP

Average Volume (3m)

14,683

Shares Outstanding

8,616,010

Dividend Yield

PE Ratio

-1.63

Earnings Per Share (EPS)

-1.45

Revenue

Net Profit

-12.47M

NeuroBo Pharmaceuticals Inc is a clinical-stage biotechnology company focused on developing and commercializing multi-modal disease-modifying therapies for viral, neuropathic, and neurodegenerative diseases, has a current portfolio of four drug candidates. The company's acquired ANA001 candidate is ... NeuroBo Pharmaceuticals Inc is a clinical-stage biotechnology company focused on developing and commercializing multi-modal disease-modifying therapies for viral, neuropathic, and neurodegenerative diseases, has a current portfolio of four drug candidates. The company's acquired ANA001 candidate is a proprietary oral niclosamide formulation in development as a treatment for patients with moderate to severe COVID-19. ANA001 is being studied in a 60-subject Phase 2/3 clinical trial conducted at up to 20 clinical sites in the USA. The company's NB-01 candidate has been shown in a Phase 2 study to significantly reduce pain symptoms associated with painful diabetic neuropathy (PDN), with a superior safety profile when compared to currently available treatments. Show more

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.neurobopharma.com

Headquarters

Wilmington, Delaware, USA

Founded

NeuroBo Pharmaceuticals Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker NRBO. The last closing price for NeuroBo Pharmaceuticals was $2.36. Over the last year, NeuroBo Pharmaceuticals shares have traded in a share price range of $ 2.08 to $ 6.7499.

NeuroBo Pharmaceuticals currently has 8,616,010 shares outstanding. The market capitalization of NeuroBo Pharmaceuticals is $20.33 million. NeuroBo Pharmaceuticals has a price to earnings ratio (PE ratio) of -1.63.

Form 8-K - Current report

Form 4 - Statement of changes in beneficial ownership of securities

Form 8-K - Current report

NeuroBo Pharmaceuticals Announces Strategic Realignment Ahead of Important Clinical Milestones with Name Change to MetaVia - Reflecting the Company's Focus on Cardiometabolic Diseases

NeuroBo Pharmaceuticals Announces Strategic Realignment Ahead of Important Clinical Milestones with Name Change to MetaVia - Reflecting the Company's Focus on Cardiometabolic Diseases PR...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0	0	2.36	2.36	2.36	0	0	CS
4	0	0	2.36	2.36	2.36	0	0	CS
12	-0.61	-20.5387205387	2.97	3.1201	2.18	14683	2.5708755	CS
26	-2.68	-53.1746031746	5.04	5.04	2.08	28678	3.22370139	CS
52	-1.14	-32.5714285714	3.5	6.7499	2.08	360498	5.28947467	CS
156	-307.24	-99.2377260982	309.6	510.8	2.08	782519	44.91996045	CS
260	-1910.44	-99.8766206608	1912.8	7200	2.08	676492	310.08345806	CS

NRBO - Frequently Asked Questions (FAQ)

What is the current NeuroBo Pharmaceuticals share price?

The current share price of NeuroBo Pharmaceuticals is $ 2.36

How many NeuroBo Pharmaceuticals shares are in issue?

NeuroBo Pharmaceuticals has 8,616,010 shares in issue

What is the market cap of NeuroBo Pharmaceuticals?

The market capitalisation of NeuroBo Pharmaceuticals is USD 20.33M

What is the 1 year trading range for NeuroBo Pharmaceuticals share price?

NeuroBo Pharmaceuticals has traded in the range of $ 2.08 to $ 6.7499 during the past year

What is the PE ratio of NeuroBo Pharmaceuticals?

The price to earnings ratio of NeuroBo Pharmaceuticals is -1.63

What is the reporting currency for NeuroBo Pharmaceuticals?

NeuroBo Pharmaceuticals reports financial results in USD

What is the latest annual profit for NeuroBo Pharmaceuticals?

The latest annual profit of NeuroBo Pharmaceuticals is USD -12.47M

What is the registered address of NeuroBo Pharmaceuticals?

The registered address for NeuroBo Pharmaceuticals is 108 WEST 13TH ST, WILMINGTON, DELAWARE, 19801

What is the NeuroBo Pharmaceuticals website address?

The website address for NeuroBo Pharmaceuticals is www.neurobopharma.com

Which industry sector does NeuroBo Pharmaceuticals operate in?

NeuroBo Pharmaceuticals operates in the PHARMACEUTICAL PREPARATIONS sector

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
BMRABiomerica Inc	$ 0.7015 (100.43%)	395.45M
KPLTKatapult Holdings Inc	$ 9.95 (42.55%)	2.46M
WLGSWang and Lee Group Inc	$ 3.97 (40.28%)	1.01M
ARQQArqit Quantum Inc	$ 28.24 (37.15%)	4.17M
DATSDatChat Inc	$ 5.78 (35.68%)	80.94M
LFLYLeafly Holdings Inc	$ 0.5711 (-60.34%)	966.5k
LUXHLuxUrban Hotels Inc	$ 0.32 (-53.50%)	4.93M
ATRAAtara Biotherapeutics Inc	$ 7.7999 (-40.73%)	2.13M
SLXNSilexion Therapeutics Corporation	$ 0.9251 (-40.70%)	7.49M
PMAXPowell Max Ltd	$ 0.8235 (-40.36%)	34.71M
BMRABiomerica Inc	$ 0.7015 (100.43%)	395.45M
ADTXAditxt Inc	$ 0.1376 (5.04%)	283.77M
ACONAclarion Inc	$ 0.0452 (6.35%)	270.98M
RGTIRigetti Computing Inc	$ 11.2256 (2.61%)	256.65M
NVDANVIDIA Corporation	$ 133.57 (-1.96%)	209.74M